303 related articles for article (PubMed ID: 30203688)
1. Wharton's Jelly-Derived Mesenchymal Stem Cell Transplantation in a Patient with Hypoxic-Ischemic Encephalopathy: A Pilot Study.
Kabataş S; Civelek E; İnci Ç; Yalçınkaya EY; Günel G; Kır G; Albayrak E; Öztürk E; Adaş G; Karaöz E
Cell Transplant; 2018 Oct; 27(10):1425-1433. PubMed ID: 30203688
[TBL] [Abstract][Full Text] [Related]
2. Circular RNAs are abundantly expressed and upregulated during repair of the damaged endometrium by Wharton's jelly-derived mesenchymal stem cells.
Sun B; Shi L; Shi Q; Jiang Y; Su Z; Yang X; Zhang Y
Stem Cell Res Ther; 2018 Nov; 9(1):314. PubMed ID: 30442201
[TBL] [Abstract][Full Text] [Related]
3. Preclinical assessment of thrombin-preconditioned human Wharton's jelly-derived mesenchymal stem cells for neonatal hypoxic-ischaemic brain injury.
Noh JH; Jeong JS; Park SJ; Jin Jung K; Lee BS; Kim WJ; Han JS; Cho MK; Sung DK; Ahn SY; Chang YS; Son HY; Jeong EJ
J Cell Mol Med; 2021 Nov; 25(22):10430-10440. PubMed ID: 34651412
[TBL] [Abstract][Full Text] [Related]
4. Comparison between the effect of human Wharton's jelly-derived mesenchymal stem cells and levetiracetam on brain infarcts in rats.
Abd El Motteleb DM; Hussein S; Hasan MM; Mosaad H
J Cell Biochem; 2018 Dec; 119(12):9790-9800. PubMed ID: 30171723
[TBL] [Abstract][Full Text] [Related]
5. Human Wharton's jelly mesenchymal stem cells: properties, isolation and clinical applications.
Borys-Wójcik S; Brązert M; Jankowski M; Ożegowska K; Chermuła B; Piotrowska-Kempisty H; Bukowska D; Antosik P; Pawelczyk L; Nowicki M; Jeseta M; Kempisty B
J Biol Regul Homeost Agents; 2019 Jan-Feb,; 33(1):119-123. PubMed ID: 30729769
[TBL] [Abstract][Full Text] [Related]
6. Characteristics and clinical applications of Wharton's jelly-derived mesenchymal stromal cells.
Liau LL; Ruszymah BHI; Ng MH; Law JX
Curr Res Transl Med; 2020 Jan; 68(1):5-16. PubMed ID: 31543433
[TBL] [Abstract][Full Text] [Related]
7. Regenerative Potential of the Product "CardioCell" Derived from the Wharton's Jelly Mesenchymal Stem Cells for Treating Hindlimb Ischemia.
Musiał-Wysocka A; Kot M; Sułkowski M; Majka M
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540534
[TBL] [Abstract][Full Text] [Related]
8. Wharton's jelly-derived mesenchymal stem cells attenuate sepsis-induced organ injury partially via cholinergic anti-inflammatory pathway activation.
Capcha JMC; Rodrigues CE; Moreira RS; Silveira MD; Dourado P; Dos Santos F; Irigoyen MC; Jensen L; Garnica MR; Noronha IL; Andrade L; Gomes SA
Am J Physiol Regul Integr Comp Physiol; 2020 Jan; 318(1):R135-R147. PubMed ID: 31596111
[TBL] [Abstract][Full Text] [Related]
9. Treatment With Human Wharton's Jelly-Derived Mesenchymal Stem Cells Attenuates Sepsis-Induced Kidney Injury, Liver Injury, and Endothelial Dysfunction.
Cóndor JM; Rodrigues CE; Sousa Moreira Rd; Canale D; Volpini RA; Shimizu MH; Camara NO; Noronha Ide L; Andrade L
Stem Cells Transl Med; 2016 Aug; 5(8):1048-57. PubMed ID: 27280799
[TBL] [Abstract][Full Text] [Related]
10. The Effect of Wharton Jelly-Derived Mesenchymal Stromal Cells and Their Conditioned Media in the Treatment of a Rat Spinal Cord Injury.
Chudickova M; Vackova I; Machova Urdzikova L; Jancova P; Kekulova K; Rehorova M; Turnovcova K; Jendelova P; Kubinova S
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31547264
[TBL] [Abstract][Full Text] [Related]
11. Thrombin Preconditioning Enhances Therapeutic Efficacy of Human Wharton's Jelly-Derived Mesenchymal Stem Cells in Severe Neonatal Hypoxic Ischemic Encephalopathy.
Kim YE; Sung SI; Chang YS; Ahn SY; Sung DK; Park WS
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31137455
[TBL] [Abstract][Full Text] [Related]
12. An Injectable Hyaluronan-Methylcellulose (HAMC) Hydrogel Combined with Wharton's Jelly-Derived Mesenchymal Stromal Cells (WJ-MSCs) Promotes Degenerative Disc Repair.
Choi UY; Joshi HP; Payne S; Kim KT; Kyung JW; Choi H; Cooke MJ; Kwon SY; Roh EJ; Sohn S; Shoichet MS; Han I
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33036383
[TBL] [Abstract][Full Text] [Related]
13. Single high-dose intravenous injection of Wharton's jelly-derived mesenchymal stem cell exerts protective effects in a rat model of metabolic syndrome.
Chan AML; Ng AMH; Yunus MHM; Idrus RH; Law JX; Yazid MD; Chin KY; Yusof MRM; Ng SN; Koh B; Lokanathan Y
Stem Cell Res Ther; 2024 Jun; 15(1):160. PubMed ID: 38835014
[TBL] [Abstract][Full Text] [Related]
14. Differentiation of human mesenchymal stem cells (MSC) to dopaminergic neurons: A comparison between Wharton's Jelly and olfactory mucosa as sources of MSCs.
Alizadeh R; Bagher Z; Kamrava SK; Falah M; Ghasemi Hamidabadi H; Eskandarian Boroujeni M; Mohammadi F; Khodaverdi S; Zare-Sadeghi A; Olya A; Komeili A
J Chem Neuroanat; 2019 Mar; 96():126-133. PubMed ID: 30639339
[TBL] [Abstract][Full Text] [Related]
15. Human chorionic-plate-derived mesenchymal stem cells and Wharton's jelly-derived mesenchymal stem cells: a comparative analysis of their potential as placenta-derived stem cells.
Kim MJ; Shin KS; Jeon JH; Lee DR; Shim SH; Kim JK; Cha DH; Yoon TK; Kim GJ
Cell Tissue Res; 2011 Oct; 346(1):53-64. PubMed ID: 21987220
[TBL] [Abstract][Full Text] [Related]
16. Retinoic acid-pretreated Wharton's jelly mesenchymal stem cells in combination with triiodothyronine improve expression of neurotrophic factors in the subventricular zone of the rat ischemic brain injury.
Sabbaghziarani F; Mortezaee K; Akbari M; Kashani IR; Soleimani M; Moini A; Ataeinejad N; Zendedel A; Hassanzadeh G
Metab Brain Dis; 2017 Feb; 32(1):185-193. PubMed ID: 27549229
[TBL] [Abstract][Full Text] [Related]
17. Regenerative potential of Wharton's jelly-derived mesenchymal stem cells: A new horizon of stem cell therapy.
Abbaszadeh H; Ghorbani F; Derakhshani M; Movassaghpour AA; Yousefi M; Talebi M; Shamsasenjan K
J Cell Physiol; 2020 Dec; 235(12):9230-9240. PubMed ID: 32557631
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells.
Batsali AK; Pontikoglou C; Koutroulakis D; Pavlaki KI; Damianaki A; Mavroudi I; Alpantaki K; Kouvidi E; Kontakis G; Papadaki HA
Stem Cell Res Ther; 2017 Apr; 8(1):102. PubMed ID: 28446235
[TBL] [Abstract][Full Text] [Related]
19. Thrombin Priming Promotes the Neuroprotective Effects of Human Wharton's Jelly-Derived Mesenchymal Stem Cells Via the HGF/AKT/STAT3 Signaling Pathway.
Ha GH; Yeon JY; Kim KH; Lee DM; Chae HY; Nam H; Lee K; Kim DO; Kim CK; Joo KM
Stem Cells Dev; 2024 Feb; 33(3-4):89-103. PubMed ID: 38164089
[TBL] [Abstract][Full Text] [Related]
20. Intrathecal Injection in A Rat Model: A Potential Route to Deliver Human Wharton's Jelly-Derived Mesenchymal Stem Cells into the Brain.
Kim H; Na DL; Lee NK; Kim AR; Lee S; Jang H
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32070050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
